论文部分内容阅读
为观察阿苯达唑乳剂对肝囊型包虫病患者的临床疗效 ,对 71例包虫病患者用阿苯达唑乳剂按每日每公斤体重12 . 5 mg剂量进行治疗 ,以 B超影像特征判定疗效 ,连续服药 3个月复查一次 (1个疗程 ) ,各疗程间不停药 ,停药时的结果为近期疗效 ,停药后最后一次随访 (6个月～ 2年 )的结果为远期疗效。平均近期疗效 :有效率 85 . 9% ,治愈率5 2 . 1% ,无效率为 14 . 1% ;平均远期疗效 :有效率 91. 7% ,治愈率 83. 4 % ,复发率为 8. 3%。该药比其它抗包虫药物疗效高 ,不良反应轻 ,安全可靠 ,可成为治疗包虫病的首选药物 ,值得临床推广使用。
To observe the clinical efficacy of albendazole emulsion on patients with hepatic cystic echinococcosis, 71 patients with hydatid disease were treated with albendazole emulsion at a dose of 12.5 mg / kg body weight per day, with B-mode ultrasound Characteristics to determine the efficacy of continuous medication 3 months to review once (1 course), the course of non-stop treatment, the results of the withdrawal time for the short-term efficacy, stopping the last follow-up (6 months to 2 years) Long-term efficacy. The average short-term efficacy: the effective rate of 85.9%, the cure rate of 52.1%, the ineffective rate was 14.1%; the average long-term efficacy: the effective rate of 91.7%, the cure rate was 83.4%, the recurrence rate was 8 3%. The drug than other anti-hydatid drug efficacy, adverse reactions, safe, reliable, can be the treatment of hydatidosis drug of choice, it is worth promoting the use of clinical.